These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27998692)
21. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma. Ramsdell JW; Fish L; Graft D; Higgins N; Kavuru M; Pleskow W; Banerji D Ann Allergy Asthma Immunol; 1998 May; 80(5):385-90. PubMed ID: 9609607 [TBL] [Abstract][Full Text] [Related]
22. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC; Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493 [TBL] [Abstract][Full Text] [Related]
23. The comparison of therapeutic effect of Clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial. Moosavi ZB; Aliabdi M; Golfakhrabadi F; Namjoyan F Arch Dermatol Res; 2020 Apr; 312(3):173-178. PubMed ID: 31707498 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
25. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
26. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. FitzGerald JM; Bleecker ER; Nair P; Korn S; Ohta K; Lommatzsch M; Ferguson GT; Busse WW; Barker P; Sproule S; Gilmartin G; Werkström V; Aurivillius M; Goldman M; Lancet; 2016 Oct; 388(10056):2128-2141. PubMed ID: 27609406 [TBL] [Abstract][Full Text] [Related]
27. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718 [TBL] [Abstract][Full Text] [Related]
28. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX). Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM; J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355 [TBL] [Abstract][Full Text] [Related]
29. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness. Nathan RA; Minkwitz MC; Bonuccelli CM Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial. Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202 [TBL] [Abstract][Full Text] [Related]
32. Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial. Grossman J; Smith LJ; Wilson AM; Thyrum PT Ann Allergy Asthma Immunol; 1999 Apr; 82(4):361-9. PubMed ID: 10227334 [TBL] [Abstract][Full Text] [Related]
33. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218 [TBL] [Abstract][Full Text] [Related]
34. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216 [TBL] [Abstract][Full Text] [Related]
35. Investigation of the efficacy of generic and brand-name salmeterol/fluticasone combination in the management of asthma: a randomized comparative trial. Panahi Y; Ghanei M; Maghsoudi H; Saffar Soflaei S; Sahebkar A Acta Biomed; 2018 Jun; 89(2):186-192. PubMed ID: 29957750 [TBL] [Abstract][Full Text] [Related]
36. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial. Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574 [TBL] [Abstract][Full Text] [Related]
37. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma. Athavale A; Souza GA; Avasthi R; Singh NP; Kale M; Taneja A; Sireesha K J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214 [TBL] [Abstract][Full Text] [Related]
38. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma. Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494 [TBL] [Abstract][Full Text] [Related]
39. The effect of the endothelin-1 receptor antagonist, bosentan, on patients with poorly controlled asthma: a 17-week, double-blind, placebo-controlled crossover pilot study. Coyle TB; Metersky ML J Asthma; 2013 May; 50(4):433-7. PubMed ID: 23363065 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma. Medley H; Orozco S; Allen A Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]